Search research articles
Contact Us
Filters
Showing results (51-60 of 61) with videos related to
Page
of 7
Sort By:
Journal of Radiation Research
|
October 10, 2017
Dose escalation via brachytherapy boost for nasopharyngeal carcinoma in the era of intensity-modulated radiation therapy and combined chemotherapy
Hsing-Lung Chao, Shao-Cheng Liu, Chih-Cheng Tsao, et al.
Head & Neck
|
January 1, 2019
Treatment outcomes with whole-field versus split-field intensity-modulated radiotherapy for patients with nasopharyngeal carcinoma
Chun-Shu Lin, Yuan-Wu Chen, Shao-Cheng Liu, et al.
Journal of X-Ray Science and Technology
|
February 4, 2017
Dosimetric and radiobiological comparison of Cyberknife and Tomotherapy in stereotactic body radiotherapy for localized prostate cancer
Chun-You Chen, Liang-Ming Lee, Hsiao-Wei Yu, et al.
JCO Oncology Practice
|
March 18, 2021
Palliative Radiotherapy Within the Veterans Health Administration: Barriers to Referral and Timeliness of Treatment
Ruchika Gutt, Sheetal Malhotra, Michael P Hagan, et al.
Cancer Research
|
December 4, 2002
Immunization with Epstein-Barr Virus (EBV) peptide-pulsed dendritic cells induces functional CD8+ T-cell immunity and may lead to tumor regression in patients with EBV-positive nasopharyngeal carcinoma
Chen-Lung Lin, Wei-Feng Lo, Tzong-Hsien Lee, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 8, 2015
Near Real-Time Assessment of Anatomic and Dosimetric Variations for Head and Neck Radiation Therapy via Graphics Processing Unit-based Dose Deformation Framework
X Sharon Qi, Anand Santhanam, John Neylon, et al.
BMC Cancer
|
April 3, 2019
Systemic and tumor-directed therapy for oligometastatic prostate cancer: study protocol for a phase II trial for veterans with de novo oligometastatic disease
Neil R Parikh, Claudia Huiza, Jill S Patel, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 5, 2021
The Clinical Cell-Cycle Risk (CCR) Score Is Associated With Metastasis After Radiation Therapy and Provides Guidance on When to Forgo Combined Androgen Deprivation Therapy With Dose-Escalated Radiation
Jonathan Tward, Lauren Lenz, Darl D Flake, et al.
European Urology Oncology
|
June 20, 2025
Pooled Analysis of the SOLAR and SATURN Clinical Trials Comparing Progression of Synchronous Versus Metachronous Prostate-specific Membrane Antigen-defined Oligometastatic Prostate Cancer Following Systemic and Tumor-directed Therapy
Jesus E Juarez Casillas, John Nikitas, Matthew B Rettig, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 16, 2025
Development and Validation of an Artificial Intelligence Digital Pathology Biomarker to Predict Benefit of Long-Term Hormonal Therapy and Radiotherapy in Men With High-Risk Prostate Cancer Across Multiple Phase III Trials
Andrew J Armstrong, Vinnie Y T Liu, Ramprasaath R Selvaraju, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 61) with videos related to
Sort By:
Page
of 7
Journal of Radiation Research
|
October 10, 2017
Dose escalation via brachytherapy boost for nasopharyngeal carcinoma in the era of intensity-modulated radiation therapy and combined chemotherapy
Hsing-Lung Chao, Shao-Cheng Liu, Chih-Cheng Tsao, et al.
Head & Neck
|
January 1, 2019
Treatment outcomes with whole-field versus split-field intensity-modulated radiotherapy for patients with nasopharyngeal carcinoma
Chun-Shu Lin, Yuan-Wu Chen, Shao-Cheng Liu, et al.
Journal of X-Ray Science and Technology
|
February 4, 2017
Dosimetric and radiobiological comparison of Cyberknife and Tomotherapy in stereotactic body radiotherapy for localized prostate cancer
Chun-You Chen, Liang-Ming Lee, Hsiao-Wei Yu, et al.
JCO Oncology Practice
|
March 18, 2021
Palliative Radiotherapy Within the Veterans Health Administration: Barriers to Referral and Timeliness of Treatment
Ruchika Gutt, Sheetal Malhotra, Michael P Hagan, et al.
Cancer Research
|
December 4, 2002
Immunization with Epstein-Barr Virus (EBV) peptide-pulsed dendritic cells induces functional CD8+ T-cell immunity and may lead to tumor regression in patients with EBV-positive nasopharyngeal carcinoma
Chen-Lung Lin, Wei-Feng Lo, Tzong-Hsien Lee, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 8, 2015
Near Real-Time Assessment of Anatomic and Dosimetric Variations for Head and Neck Radiation Therapy via Graphics Processing Unit-based Dose Deformation Framework
X Sharon Qi, Anand Santhanam, John Neylon, et al.
BMC Cancer
|
April 3, 2019
Systemic and tumor-directed therapy for oligometastatic prostate cancer: study protocol for a phase II trial for veterans with de novo oligometastatic disease
Neil R Parikh, Claudia Huiza, Jill S Patel, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 5, 2021
The Clinical Cell-Cycle Risk (CCR) Score Is Associated With Metastasis After Radiation Therapy and Provides Guidance on When to Forgo Combined Androgen Deprivation Therapy With Dose-Escalated Radiation
Jonathan Tward, Lauren Lenz, Darl D Flake, et al.
European Urology Oncology
|
June 20, 2025
Pooled Analysis of the SOLAR and SATURN Clinical Trials Comparing Progression of Synchronous Versus Metachronous Prostate-specific Membrane Antigen-defined Oligometastatic Prostate Cancer Following Systemic and Tumor-directed Therapy
Jesus E Juarez Casillas, John Nikitas, Matthew B Rettig, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 16, 2025
Development and Validation of an Artificial Intelligence Digital Pathology Biomarker to Predict Benefit of Long-Term Hormonal Therapy and Radiotherapy in Men With High-Risk Prostate Cancer Across Multiple Phase III Trials
Andrew J Armstrong, Vinnie Y T Liu, Ramprasaath R Selvaraju, et al.
Page
of 7